Skip to main content
OpenTrials
Completed

NCT Number: NCT07572305

Effects of Virtual Reality After Liver Transplantation

This randomized controlled study aims to evaluate the effects of a virtual reality intervention on pain, fatigue and vital signs in patients during the early postoperative period after liver transplantation. Postoperative symptoms such as pain and fatigue may negatively affect recovery and patient comfort. Virtual reality has emerged as a non-pharmacological method that may help reduce these symptoms by providing distraction and relaxation.

A total of 84 patients were randomly assigned to an experimental group or a control group. The experimental group received a 20-minute virtual reality session, while the control group received standard care. Pain, fatigue and vital signs were measured before and after the intervention.

This study aims to determine whether virtual reality can improve patient comfort and physiological stability and support recovery after liver transplantation.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Inonu University Liver Transplantation Institute

Malatya, Turkey (Türkiye)

About this study

This study was designed as a prospective, randomized controlled, single-blind trial to evaluate the effects of a virtual reality intervention on pain, fatigue, and vital signs in patients during the early postoperative period after liver transplantation.

Liver transplantation is a life-saving procedure; however, patients frequently experience postoperative symptoms such as pain and fatigue, which may negatively affect recovery, physiological stability, and overall patient comfort. Non-pharmacological interventions have gained increasing attention in recent years as supportive approaches to improve postoperative outcomes. Virtual reality is an emerging technology that provides immersive distraction and relaxation, potentially reducing symptom perception and enhancing patient well-being.

The study was conducted in the organ transplantation clinic of a university hospital between May 2025 and January 2026. A total of 84 patients who met the inclusion criteria were randomly assigned to either the experimental group (n=42) or the control group (n=42) using a computer-based randomization method.

Patients in the experimental group received a 20-minute virtual reality intervention during the early postoperative period, while patients in the control group received standard care without additional intervention. Pain levels were assessed using the Numerical Rating Scale (NRS), fatigue levels were measured using the Brief Fatigue Inventory (BFI), and vital signs including heart rate, respiratory rate, and blood pressure were recorded. All measurements were obtained before the intervention and 15 minutes after the intervention.

The primary objective of the study was to determine the effect of virtual reality on fatigue levels. Secondary outcomes included pain and vital signs. Data were analysed using appropriate statistical methods, and statistical significance was set at p<0.05.

This study aims to contribute to the evidence base regarding the effectiveness of virtual reality as a non-pharmacological nursing intervention and to support its integration into clinical practice to improve postoperative care in liver transplantation patients.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥18 years
  • Underwent liver transplantation
  • In the early postoperative period
  • Able to communicate verbally
  • No diagnosed psychiatric disorder
  • Hemodynamically stable
  • Pain score ≥4 on the Numerical Rating Scale (NRS)
  • Willing to participate in the study

Exclusion criteria

  • Presence of severe postoperative complications
  • Cognitive impairment or inability to understand instructions
  • Visual or hearing impairments preventing use of virtual reality
  • History of motion sickness or vertigo related to virtual reality use
  • Chronic diseases that may affect fatigue or vital signs (e.g., uncontrolled cardiovascular or respiratory diseases)
  • Refusal to participate

Treatment and study plan

Virtual Reality Intervention

Behavioral

A 20 minute immersive virtual reality session was administered using a headmounted display during the early postoperative period following liver transplantation.

Standard care

Other

Participants received routine postoperative care without any additional intervention

Primary outcomes

  1. Change in fatigue severity

    Time frame: Baseline and 15 minutes after intervention

    Change in fatigue severity measured using the Brief Fatigue Inventory (BFI) total score (range: 0-10; higher scores indicate greater fatigue)

Secondary outcomes

  1. Change in pain intensity

    Time frame: Baseline and 15 minutes after intervention

    Measured using the Numerical Rating Scale (NRS) (range: 0-10; higher scores indicate greater pain)

  2. Change in heart rate (beats per minute)

    Time frame: Baseline and 15 minutes after intervention

    Change in heart rate measured in beats per minute (bpm). Heart rate was recorded as part of routine vital sign monitoring to evaluate the physiological response to the virtual reality intervention. Lower values may indicate improved relaxation and autonomic stability.

  3. Change in systolic and diastolic blood pressure (mmHg)

    Time frame: Baseline and 15 minutes after intervention

    Change in systolic and diastolic blood pressure measured in millimeters of mercury (mmHg). Blood pressure was recorded as part of routine vital sign monitoring to evaluate the cardiovascular response to the virtual reality intervention. Lower values may indicate improved physiological stability and relaxation.

  4. Change in systolic and diastolic blood pressure (mmHg)

    Time frame: Baseline and 15 minutes after intervention

    Change in systolic and diastolic blood pressure measured in millimeters of mercury (mmHg). Blood pressure was assessed as part of routine vital sign monitoring to evaluate the cardiovascular response to the intervention. Lower values may indicate improved physiological stability.

Sponsors and collaborators

Lead sponsor

Malatya Turgut Ozal University

Other

Registry information

Official study title

Effects of Virtual Reality on Pain, Fatigue and Vital Signs After Liver Transplantation A Randomized Controlled Trial

Acronym: VR-LT

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
May 7, 2026
Registry last updated
May 7, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.